Biosynthesis and characterization of a novel fibrinolytic alkaline serine protease from newly isolated Bacillus flexusBF12 for biomedical applications.
CONCLUSION: The Bacillus flexus BF12 fibrinolytic enzyme shows promising potentials in nutraceutical and food fortification applications. The application of fibrinolytic enzymes could prevent CVDs.
PMID: 33208066 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Biotechnology - Category: Biotechnology Authors: Raj TS, Athimoolam S, Vijayaraghavan P Tags: Curr Pharm Biotechnol Source Type: research
More News: Biotechnology | Cardiology | Cardiovascular | Dialysis | Heart | Heart Attack | Heart Disease | Hypertension | India Health | Ischemic Stroke | Nutrition | Peripheral Vascular Disease (PVD) | Statistics | Stroke | Thrombosis